Semaglutide Inj recalled over sterility concerns
- Recall date
- February 26, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- New Life Pharma LLC recalls Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061,…
- Recall number
- D-0393-2026
- FDA classification
- Class II
- Brand / firm
- New Life Pharma LLC
- Sold / distributed
- OH
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06
Get recall alerts
Free email alert whenever New Life Pharma LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: New Life Pharma LLC